TrialProstate cancer and prostatic diseases2020

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.

Ronald Tutrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.